Filter
2249
Text search:
clinical
trials
Featured
Recommendations
245
New Publications
383
Language
Document type
No document type
1107
Guidelines
442
Studies & Reports
386
Manuals
114
Fact sheets
84
Strategic & Response Plan
46
Training Material
29
Situation Updates
13
Resource Platforms
12
Infographics
10
Brochures
3
Videos
2
Countries / Regions
India
110
Global
103
South Africa
54
Kenya
36
Western and Central Europe
36
Africa
29
Uganda
24
Sierra Leone
22
Ethiopia
22
Zambia
21
East and Southern Africa
21
Nigeria
20
West and Central Africa
20
Latin America and the Carribbean
19
Liberia
18
Brazil
18
Malawi
17
Russia
17
Nepal
16
Tanzania
16
Eastern Europe
16
Ghana
15
Philippines
15
Rwanda
15
Ukraine
15
Zimbabwe
14
Indonesia
12
Germany
11
Bangladesh
11
Namibia
11
South–East Asia Region
11
Congo, Democratic Republic of
10
Mozambique
10
Asia
10
Guinea
9
Middle East and North Africa
9
South Sudan
8
Cameroon
7
USA
6
Cambodia
6
Peru
6
Eswatini/ Swaziland
6
Lesotho
6
Thailand
5
Colombia
5
Botswana
5
Angola
5
Eastern Europe and Central Asia
5
Albania
5
Burkina Faso
4
Senegal
4
China
4
Vietnam
4
North America
4
United Kingdom
4
Mali
3
Guinea-Bissau
3
Haiti
3
Sudan
3
Argentina
3
Myanmar / Burma
3
Chile
3
Laos
3
France
3
Spain
3
Côte d’Ivoire / Ivory Coast
2
Pakistan
2
Iraq
2
Lebanon
2
Syria
2
Chad
2
Burundi
2
Sri Lanka
2
Tajikistan
2
Estonia
2
Georgia
2
Morocco
1
Saudi Arabia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Ireland
1
Singapore
1
Benin
1
Ecuador
1
Greece
1
Madagascar
1
Paraguay
1
Canada
1
Bulgaria
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Denmark
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
533
Clinical Guidelines
326
Public Health
143
Women & Child Health
130
Key Resources
40
Pharmacy & Technologies
32
Capacity Building
22
Toolboxes
Mental Health
290
COVID-19
266
HIV
255
TB
183
NTDs
109
NCDs
89
AMR
67
Ebola & Marburg
61
Pharmacy
51
Caregiver
50
Malaria
45
Rapid Response
29
Disability
27
Planetary Health
24
Global Health Education
19
Refugee
18
Polio
13
Health Financing Toolbox
12
2.0 Rapid Response
12
Conflict
11
Zika
11
Cholera
10
Natural Hazards
4
Social Ethics
3
Specific Hazards
2
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700
...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year.
...
The method, entitled “elicit-provide-elicit”, is a patient centred method which is adaptable to a range of clinical situations. Recent clinical trial
...
BioDrugs. 2023 Sep 20;37(6):737–756. doi: 10.1007/s40259-023-00623-4
There are many malaria vaccine candidates in development, with more than a dozen of these in clinical development. RTS,S/AS01 (also known as Mosquirix) is the most advanced mal
...
The article from the African Journal of Thoracic and Critical Care Medicine provides updated guidelines on endoscopic lung volume reduction (ELVR) for treating advanced emphysema, a severe form of chronic obstructive pulmonary disease (COPD), which is prevalent in South Africa and other low- and mid
...
Diabetes mellitus (DM) is a global epidemic with significant morbidity. Diabetic
retinopathy (DR) is the specific microvascular complication of DM and affects 1 in 3 persons with DM. DR remains a leading cause of vision loss in working adult populations. Patients with severe levels of DR are report
...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those
...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie
...
The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017.
Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to
...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-cli
...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM
...
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h
...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing
...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps
...
The technical note from the Global Task Force on Cholera Control (GTFCC) examines the risks and benefits of vaccinating pregnant women with WHO-prequalified oral cholera vaccines (OCVs) during mass vaccination campaigns. It highlights that three WHO-approved vaccines (Dukoral®, Shanchol™, and Euv
...
Two decades of epidemiological research shows that silent cerebrovascular disease is common and is associated with future risk for stroke and dementia. It is the most common incidental finding on brain scans. To summarize evidence on the diagnosis and management of silent cerebrovascular disease to
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inpu
...
